CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis
Canada - TSX-V:LOVE - CA13765U2002 - Common Stock
1.62 CAD
-0.03 (-1.82%)
Taking everything into account, LOVE scores 6 out of 10 in our fundamental rating. LOVE was compared to 3 industry peers in the Personal Care Products industry. While LOVE has a great health rating, there are worries on its profitability. LOVE is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
In the past year LOVE was profitable.
In the past year LOVE had a positive cash flow from operations.
In multiple years LOVE reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
1.2 Ratios
LOVE has a Return On Assets of 9.12%. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 15.74%, LOVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 15.74% | ||
| ROIC | N/A |
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LOVE's Profit Margin of 15.15% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
LOVE has a Gross Margin of 14.02%. This is in the lower half of the industry: LOVE underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of LOVE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 15.15% | ||
| GM | 14.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
2. Health
2.1 Basic Checks
LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LOVE has been reduced compared to 1 year ago.
LOVE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LOVE has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.03 indicates that LOVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of LOVE (2.03) is better than 66.67% of its industry peers.
The Debt to FCF ratio of LOVE is 2.92, which is a good value as it means it would take LOVE, 2.92 years of fcf income to pay off all of its debts.
LOVE has a better Debt to FCF ratio (2.92) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that LOVE is not too dependend on debt financing.
LOVE's Debt to Equity ratio of 0.41 is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 2.92 | ||
| Altman-Z | 2.03 |
ROIC/WACCN/A
WACC7.11%
2.3 Liquidity
LOVE has a Current Ratio of 2.43. This indicates that LOVE is financially healthy and has no problem in meeting its short term obligations.
LOVE has a Current ratio of 2.43. This is in the better half of the industry: LOVE outperforms 66.67% of its industry peers.
A Quick Ratio of 1.01 indicates that LOVE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.01, LOVE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.43 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 189.86% over the past year.
Looking at the last year, LOVE shows a very strong growth in Revenue. The Revenue has grown by 33.04%.
The Revenue has been growing by 108.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.26%
Revenue 1Y (TTM)33.04%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%39.85%
3.2 Future
The Earnings Per Share is expected to grow by 42.03% on average over the next years. This is a very strong growth
LOVE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.04% yearly.
EPS Next Y43.26%
EPS Next 2Y51.4%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue Next Year27.9%
Revenue Next 2Y22.09%
Revenue Next 3Y19.04%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.53, the valuation of LOVE can be described as very reasonable.
Based on the Price/Earnings ratio, LOVE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.56. LOVE is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.02, the valuation of LOVE can be described as very reasonable.
100.00% of the companies in the same industry are more expensive than LOVE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.62. LOVE is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.53 | ||
| Fwd PE | 10.02 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than LOVE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.46 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LOVE's earnings are expected to grow with 42.03% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y51.4%
EPS Next 3Y42.03%
5. Dividend
5.1 Amount
LOVE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:LOVE (11/14/2025, 7:00:00 PM)
1.62
-0.03 (-1.82%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners27.72%
Ins Owner ChangeN/A
Market Cap153.74M
Revenue(TTM)102.43M
Net Income(TTM)15.52M
Analysts80
Price Target3.06 (88.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.53 | ||
| Fwd PE | 10.02 | ||
| P/S | 1.5 | ||
| P/FCF | 9.46 | ||
| P/OCF | 7.55 | ||
| P/B | 1.56 | ||
| P/tB | 1.56 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.17
EY10.49%
EPS(NY)0.16
Fwd EY9.98%
FCF(TTM)0.17
FCFY10.57%
OCF(TTM)0.21
OCFY13.25%
SpS1.08
BVpS1.04
TBVpS1.04
PEG (NY)0.22
PEG (5Y)N/A
Graham Number1.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 15.74% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 15.15% | ||
| GM | 14.02% | ||
| FCFM | 15.87% |
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
F-Score8
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 2.92 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 66.23% | ||
| Cap/Sales | 4.02% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 104.74% | ||
| Current Ratio | 2.43 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 2.03 |
F-Score8
WACC7.11%
ROIC/WACCN/A
Cap/Depr(3y)228.25%
Cap/Depr(5y)410.31%
Cap/Sales(3y)22.24%
Cap/Sales(5y)120%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.26%
EPS Next Y43.26%
EPS Next 2Y51.4%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue 1Y (TTM)33.04%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%39.85%
Revenue Next Year27.9%
Revenue Next 2Y22.09%
Revenue Next 3Y19.04%
Revenue Next 5YN/A
EBIT growth 1Y33.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y60.25%
EBIT Next 5YN/A
FCF growth 1Y228.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3771.44%
OCF growth 3YN/A
OCF growth 5YN/A
CANNARA BIOTECH INC / LOVE.CA FAQ
What is the fundamental rating for LOVE stock?
ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA.
What is the valuation status for LOVE stock?
ChartMill assigns a valuation rating of 8 / 10 to CANNARA BIOTECH INC (LOVE.CA). This can be considered as Undervalued.
What is the profitability of LOVE stock?
CANNARA BIOTECH INC (LOVE.CA) has a profitability rating of 3 / 10.
What is the financial health of CANNARA BIOTECH INC (LOVE.CA) stock?
The financial health rating of CANNARA BIOTECH INC (LOVE.CA) is 7 / 10.
What is the earnings growth outlook for CANNARA BIOTECH INC?
The Earnings per Share (EPS) of CANNARA BIOTECH INC (LOVE.CA) is expected to grow by 43.26% in the next year.